Skip to main content

Human/Mouse Caspase-8 Antibody

R&D Systems, part of Bio-Techne | Catalog # AF1650

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
AF1650
AF1650-SP

Key Product Details

Validated by

Biological Validation

Species Reactivity

Validated:

Human, Mouse

Cited:

Human, Mouse, Complex Species Category, Xenograft

Applications

Validated:

Simple Western, Western Blot

Cited:

Immunohistochemistry, Neutralization, Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Product Specifications

Immunogen

E. coli-derived recombinant human Caspase-8
Ser217-Asp384 (Asp285His) (p18 subunit), Leu385-Asp479 (p10 subunit)
Accession # Q14790

Specificity

Detects human/mouse Caspase-8 and cleavage products. Detects multiple isoforms of Caspase-8.

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for Human/Mouse Caspase-8 Antibody

Detection of Human Caspase-8 antibody by Western Blot.

Detection of Human Caspase‑8 by Western Blot.

Western blot shows lysates of Jurkat human acute T cell leukemia cell line untreated (-) or treated (+) with 1 mM staurosporine (STS) for for 3 hours. PVDF membrane was probed with 0.5 µg/mL of Rabbit Anti-Human/Mouse Caspase-8 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1650), followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). For additional reference Recombinant Human Caspase-8 (Catalog # 705-C8) was included. Specific bands were detected for Caspase-8 precursor at approximately 57-60 kDa (as indicated). In STS-treated samples, specific bands were detected for Caspase-8 p41/43 subunit at approximately 41 and 43 kDa (as indicated) and Caspase-8 p18, p14, and p10 subunits at approximately 18 kDa, 14 kDa, and 10 kDa, respectively (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 4.
Detection of Human Caspase-8 antibody by Simple WesternTM.

Detection of Human Caspase‑8 by Simple WesternTM.

Simple Western lane view shows lysates of Jurkat human acute T cell leukemia cell line untreated (-) or treated (+) with 1 mM Staurosporine (STS) for 3 hours, loaded at 0.2 mg/mL. Specific bands were detected for Caspase‑8 at approximately 58-62 kDa (as indicated) using 5 µg/mL of Rabbit Anti-Human/Mouse Caspase‑8 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1650). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.
Detection of Human Caspase-8 by Western Blot

Detection of Human Caspase-8 by Western Blot

Western blot analysis of the expression of a number of proteins impacting proliferation and survival of ovarian cancer cells 48 hours after alteration of the Spry1 expression. Results indicate activation of apoptotic processes detected as overexpression of the pro-apoptotic Bax, decreased expression of the antiapoptotic proteins Bcl-2 and Bcl-xl, attenuation of procaspases 3, 7, 8 and 9 and cleavage of PARP in the Spry1-transfected SKOV-3 cells (left). Moreover, reduced expression of the activated forms of ERK and AKT along with increased expression of PTEN with concomitant decrease of phospho-PTEN (right) implicates repression of ERK as well as of AKT, with involvement of PTEN for the latter, in Spry1-induced inhibition of cell proliferation and survival. No significant change in the expression pattern of these proteins was found in the Spry1-silenced 1A9 cells. Image collected and cropped by CiteAb from the following publication (https://ovarianresearch.biomedcentral.com/articles/10.1186/1757-2215-7-61), licensed under a CC-BY license. Not internally tested by R&D Systems.

Applications for Human/Mouse Caspase-8 Antibody

Application
Recommended Usage

Simple Western

5 µg/mL
Sample: Jurkat human acute T cell leukemia cell line treated with Staurosporine (STS)

Western Blot

0.5 µg/mL
Sample: Jurkat human acute T cell leukemia cell line treated with staurosporine

Reviewed Applications

Read 1 review rated 4 using AF1650 in the following applications:

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: Caspase-8

Caspase-8 (Cysteine-aspartic acid protease 8/Casp8a; also named MCH5, FLICA and MACH alpha1) is a 28 kDa member of the peptidase C14A family of enzymes (1, 2, 3). It is widely expressed and is considered an initiating caspase for the apoptotic cascade (4). Caspase-8 acts on a wide variety of substrates, including procaspases-3, 4, 6, 7, 9 and 10, c-FLIPL and procaspase-8 itself (1, 5, 6). Human procaspase-8a is a 54‑56 kDa, 479 amino acid (aa) protein (4, 7, 8, 9). It contains two N-terminal death domains (aa 1‑177), followed by a catalytic site that utilizes His317Gly318 plus Cys360. Normally, it is an inactive, cytosolic monomer (1, 10, 11). But following death-domain (DD) containing receptor oligomerization, Caspase-8 is recruited to the death-inducing signaling complex (DISC) that forms around the death domains of the oligomerized receptor (12). FADD/CAP-1 is recruited first, followed by procaspase-8/CAP-4 and, possibly, c-FLIPL and procaspase-10 (12). The recruitment, or concentration, of procaspase-8 induces homodimerization. This act alone is sufficient for activation. However, the activity level is modest at best, and appears to be directed towards either itself, or c-FLIPL, which is known to form a functional heterodimer with procaspase-8 (5, 11). When directed towards itself, autocleavage occurs first between Asp374Ser375, generating a 43 kDa (p43) N-terminal (aa 1‑374) and an 11 kDa C-terminal (aa 375 - 479) fragment. The C-terminus is further cleaved between Asp384Leu385 to generate a mature p10 subunit (aa 385‑479). The p43 subunit is next cleaved twice, once between Asp216Ser217, and again between Asp210Ser211 to generate a 26 kDa DD-containing prodomain (aa 1‑210) with an additional 18 kDa mature p18 subunit (aa 217‑374) (12). p18 and p10 noncovalently associate to form a 28 kDa heterodimer, which subsequently associates with another p18:p10 heterodimer to form an active, mature Caspase-8 molecule. This leaves the DISC to act on downstream apoptotic procaspases. In the event procaspase-8 comes to the DISC complexed with c-FLIPL, c-FLIPL will be cleaved by procaspase-8, generating a p43 fragment that is analogous to the Caspase-8 p43 subunit. This fragment, however, appears not to be an intermediate in a proteolytic cascade. Rather, it serves as a functional subunit, interacting with TRAF2 and activating NF kappaB. This may account for many of the nonapoptotic activities associated with Caspase-8 (5, 6, 13). Mature human and mouse Caspase-8a heterodimers are 73% aa identical (14).

References

  1. Chowdhury, I. et al. (2008) Comp. Biochem. Physiol. B 151:10.
  2. Boatright, K.M. & G.S. Salvesen (2003) Curr. Opin. Cell Biol. 15:725.
  3. Launay, S. et al. (2005) Oncogene 24:5137.
  4. Srinivasula, S.M. et al. (1996) Proc. Natl. Acad. Sci. USA 93:14486.
  5. Hughes, M.A. et al. (2009) Mol. Cell 35:265.
  6. Lamkanfi, M. et al. (2007) Cell Death Differ. 14:44.
  7. Fernandes-Alnemri, T. et al. (1996) Proc. Natl. Acad. Sci. USA 93:7464.
  8. Boldin, M.P. et al. (1996) Cell 85:803.
  9. Muzio, M. et al. (1996) Cell 85:817.
  10. Donepudi, M. et al. (2003) Mol. Cell 11:543.
  11. Boatright, K.M. et al. (2003) Mol. Cell 11:529.
  12. Golks, A. et al. (2006) Cell Death Differ. 13:489.
  13. Scaffidi, C. et al. (1997) J. Biol. Chem. 272:26953.
  14. Sakamaki, K. et al. (1998) Eur. J. Biochem. 253:399.

Alternate Names

CASP8, Caspase8, Mch5

Entrez Gene IDs

841 (Human); 12370 (Mouse)

Gene Symbol

CASP8

UniProt

Additional Caspase-8 Products

Product Documents for Human/Mouse Caspase-8 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Human/Mouse Caspase-8 Antibody

For research use only

Loading...
Loading...
Loading...
Loading...
Loading...